- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
+23.07| Last Update: 05/24/13 - 4:00 PM EDT |
| Volume: 914,930 |
| YTD Performance: -2.43% |
| Open: $492.00 |
| Previous Close: $478.46 |
| 52 Week Range: $455.18 - $585.67 |
| Oustanding Shares: 40,161,022 |
| Market Cap: 19,215,442,586 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $4.32 | $4.24 | $17.94 | $20.81 |
| Number of Analysts | 12 | 11 | 11 | 12 |
| High Estimate | $4.51 | $4.50 | $18.50 | $21.51 |
| Low Estimate | $4.20 | $3.96 | $17.58 | $20.24 |
| Prior Year | $3.75 | $4.46 | $15.98 | $17.94 |
| Growth Rate (Year over Year) | 15.16% | -4.87% | 12.27% | 15.98% |
It was good to see, if only briefly.
There are plenty of solid earnings trades to choose from over the next day or so.
Don't try to grab a trade ahead of earnings.
The momentum favorite gets slammed on news of an FDA investigation.
Intuitive Surgical upgraded at CantorISRG was upgraded from Hold to Buy, Cantor Fitzgerald said. $575 price target. Stock has overreactd to news of the FDA probe.
Intuitive Surgical upgraded at GoldmanISRG was upgraded to Buy, Goldman Sachs said. $715 price target. Fundamentals appear to be improving.
There continues to be solid sector rotation, and you have to obey the price action above all else.
Intuitive Surgical numbers raised at LazardShares of ISRG now seen reaching $625, according to Lazard Capital Markets. Estimates also increased, as the company is seeing higher growth across the board. Buy rating.
Sometimes you can catch them using price targets to hedge their ratings.
Contributor Ken Shreve takes a look at upcoming data and some key earnings reports in a shortened week of trading.